血浆组织血型ABO系统转移酶水平与未来静脉血栓栓塞风险:HUNT研究
基于HUNT研究第三次调查的294例 incident VTE 病例和1066例年龄性别加权随机抽样亚队列,检测2006-2008年基线血浆BGAT水平。BGAT最高四分位组较低四分位组VTE风险约高2倍(HR 2.12,95%CI 1.39-3.22),无诱因VTE(HR 3.71)和深静脉血栓(HR 3.28)关联更强;校正VWF或FVIII后关联中度减弱。
要点
- ABO单倍型(A1/A2/B/O1/O2)可解释约80%的血浆BGAT水平变异。
- BGAT最高四分位组较低四分位组VTE风险升高(HR 2.12,95%CI 1.39-3.22)。
- 无诱因VTE和深静脉血栓的关联更为显著(HR分别为3.71和3.28)。
核心结论
- 血浆BGAT水平升高与未来VTE风险增加相关,且该关联超出VWF和FVIII所能解释的范围。
研究设计与样本
- 研究纳入HUNT研究第三次调查的294例 incident VTE 病例和1066例年龄性别加权随机抽样亚队列,基线血浆样本采集于2006-2008年,采用SomaScan适配体7K平台检测蛋白,使用加权Cox回归估计风险比。
主要发现
- ABO单倍型(A1/A2/B/O1/O2)可解释约80%的血浆BGAT水平变异。
- 在年龄、性别和样本批次校正模型中,BGAT最高四分位组较低四分位组VTE风险升高(HR 2.12,95%CI 1.39-3.22)。
- 无诱因VTE的HR为3.71(95%CI 1.79-7.67),深静脉血栓的HR为3.28(95%CI 1.63-6.59)。
- 进一步校正体重指数、C反应蛋白和估算肾小球滤过率后HR相似,加入VWF或FVIII血浆水平后关联中度减弱。
关键数值与推荐
- BGAT最高四分位组 vs 最低四分位组:VTE的HR 2.12(95%CI 1.39-3.22)。
- 无诱因VTE的HR 3.71(95%CI 1.79-7.67)。
- 深静脉血栓的HR 3.28(95%CI 1.63-6.59)。
临床怎么用
- 作者认为,血浆BGAT水平升高与未来VTE风险增加相关,且该关联超出VWF和FVIII所能解释的范围。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The non-O blood group is a well-established risk factor for venous thromboembolism (VTE). However, the association between plasma levels of the histo-blood group ABO system transferase (BGAT), the gene product of the ABO locus, and VTE risk remains unclear. We aimed to investigate the association between plasma BGAT levels and risk of future VTE, and whether this relationship was mediated by plasma von Willebrand factor (VWF) or coagulation factor VIII (FVIII), as VWF is glycosylated by BGAT. Incident VTE-cases (n = 294) and a randomly sampled age- and-sex-weighted subcohort (n = 1066) were derived from the third survey of the Trøndelag Health Study. Baseline plasma samples (2006-2008) were subjected to the SomaScan aptamer-based-7K platform for protein measurements. Weighted Cox regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) across BGAT quartiles. We found that ABO haplotypes (A1/A2/B/O1/O2) explained ≈80% of the BGAT plasma variability. Participants with BGAT levels in the highest quartile had 2-fold higher VTE risk (HR, 2.12; 95% CI, 1.39-3.22) compared with those with BGAT in the lowest quartile in age-, sex-, and sample batch-adjusted models. The associations were particularly pronounced for unprovoked VTE (HR, 3.71; 95% CI, 1.79-7.67) and deep vein thrombosis (HR, 3.28; 95% CI, 1.63-6.59). The HRs were similar after further adjustment for body mass index, C-reactive protein, and estimated glomerular filtration rate, and moderately attenuated when adding VWF or FVIII plasma levels to the models. Our findings indicate that elevated BGAT plasma levels are associated with increased risk of future VTE beyond what is explained by VWF and FVIII.
引用
- Onsaker AL, Arntzen AY, Trégouët DA, et al. Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study. Blood. 2025. PMID: 40009491. doi:10.1182/blood.2024025923
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。